Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of INO will rise by +5.22% over the next 2 Weeks and hit $1.95 by Wednesday, March 11, 2026. In that time frame, INO's share price is expected to range between $1.89 and $2.01.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 11, 2026 | 1.89 | 1.95 | 2.01 |
| Mar 10, 2026 | 1.88 | 1.94 | 2.01 |
| Mar 9, 2026 | 1.90 | 1.96 | 2.03 |
| Mar 6, 2026 | 1.85 | 1.91 | 1.96 |
| Mar 5, 2026 | 1.84 | 1.90 | 1.96 |
| Mar 4, 2026 | 1.85 | 1.91 | 1.97 |
| Mar 3, 2026 | 1.84 | 1.90 | 1.97 |
| Mar 2, 2026 | 1.86 | 1.92 | 1.98 |
| Feb 27, 2026 | 1.81 | 1.87 | 1.93 |
| Feb 26, 2026 | 1.81 | 1.87 | 1.93 |
INO shares fell -2.12% in Wednesday, February 25, 2026's trading session, dropping from a previous close of $1.89 to move at $1.85. The stock demonstrated notable intraday movement (see INO's key stats for a full breakdown), fluctuating between $1.85 and $1.94, a +4.59% trading range. While recent weeks have seen some volatility, INO has managed to secure a +14.91% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 855.35K shares changing hands, 1.37M fewer than the previous session. This amounted to $1.58M in total market activity.
Will INO Continue Its Upward Trend?
According to analyst ratings and projections for INO, Inovio Pharmaceuticals, Inc. shares are anticipated to increase by +7.81%, potentially reaching $2.01 per share by March 11, 2026. Short-term technical indicators currently suggest a neutral sentiment for INO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the INO stock forecast, now is a good time to buy INO stock because its current trading price is -4.96% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on INO covering social and institutional perspectives.
INO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into INO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 55.95% to 68.38%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 49.55%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.81%, maintains a neutral outlook for the long term. Insights into INO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Inovio Pharmaceuticals Short-Term Forecasts
INO Forecast For Next 5 Days
Our algorithm anticipates Inovio Pharmaceuticals (INO) stock could hit $1.77 by Mar 04, 2026. This represents a -4.51% fall from today's price, following a -1.95% change over the past five days.
INO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Inovio Pharmaceuticals, Inc. (INO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.70, which would mean a -8.11% decrease from the current price of $1.85. Projections for this period range from a high of $2.08 to a low of $1.32.
INO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Inovio Pharmaceuticals's price over the next three months point to a rise. INO stock is expected to peak at $5.54 on Apr 03, 2026 after potentially dipping to $3.31 on Feb 26, 2026. On average, INO is likely to trade around $4.39 in the coming 90 days.
Inovio Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Inovio Pharmaceuticals (INO) is expected to trade between $0.00 and $5.57 throughout 2026. This would result in an average price of $4.65, potentially offering investors a +151.35% return from current levels.
Inovio Pharmaceuticals, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Inovio Pharmaceuticals, Inc. (INO) is positioned to show a strong performance in February 2026. The price is predicted to move between $3.31 and $3.90, settling at an average of $3.60. This could translate to a +94.59% gain.
March 2026
Based on current market signals, Inovio Pharmaceuticals, Inc. is projected to trend march 2026. We forecast a trading range from $3.65 to $5.46, with a likely average price of $4.46. Investors could expect a potential return of +141.08%.
April 2026
Our predictive algorithms indicate Inovio Pharmaceuticals, Inc. stock may see a shift in April 2026. The expected range spans $3.70–$5.54, with an average target of $4.64. This represents a positive outlook and a possible gain of +150.81%.
May 2026
Analyzing established trends, Inovio Pharmaceuticals, Inc. looks set to move in May 2026. Projections place the stock between $3.46 and $4.71, averaging around $4.13. This suggests a +123.24% gain from current levels.
June 2026
Market indicators suggest Inovio Pharmaceuticals, Inc. could experience notable changes during June 2026. Prices could fluctuate within $3.82 to $5.19, with a midpoint forecast of $4.67. The stock might deliver a +152.43% gain.
July 2026
Forecasting for July 2026, models estimate that Inovio Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $3.17 and $5.10, averaging $4.55. This signals a positive trajectory with potential returns around +145.95%.
August 2026
According to our latest forecast models, Inovio Pharmaceuticals, Inc. (INO) is positioned to show a strong performance in August 2026. The price is predicted to move between $3.02 and $5.46, settling at an average of $5.07. This could translate to a +174.05% gain.
September 2026
Based on current market signals, Inovio Pharmaceuticals, Inc. is projected to trend september 2026. We forecast a trading range from $1.66 to $5.57, with a likely average price of $5.24. Investors could expect a potential return of +183.24%.
October 2026
Our predictive algorithms indicate Inovio Pharmaceuticals, Inc. stock may see a shift in October 2026. The expected range spans $0.69–$4.43, with an average target of $4.98. This represents a positive outlook and a possible gain of +169.19%.
November 2026
Analyzing established trends, Inovio Pharmaceuticals, Inc. looks set to move in November 2026. Projections place the stock between $0.00 and $4.32, averaging around $5.44. This suggests a +194.05% gain from current levels.
December 2026
Market indicators suggest Inovio Pharmaceuticals, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $3.22, with a midpoint forecast of $3.54. The stock might deliver a +91.35% gain.
January 2027
Forecasting for January 2027, models estimate that Inovio Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.69, averaging $4.92. This signals a positive trajectory with potential returns around +165.95%.
February 2027
According to our latest forecast models, Inovio Pharmaceuticals, Inc. (INO) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $1.93, settling at an average of $4.16. This could translate to a +124.86% gain.
INO's history of dividends and stock splits also plays a role in long-term investor confidence.

